臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jen chang ko"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 126-150 of 290 (12 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-03-11T08:34:20Z	Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan	Lee M.-R.;Ho C.-M.;Lee C.-H.;Lee M.-C.;Chang L.-Y.;Yu K.-L.;Jen-Chang Ko;Wang J.-Y.;Wang J.-T.;Lee L.-N.; MENG-RUI LEE; Cheng-Maw Ho; Chih-Hsin Lee; Ming-Chia Lee; LIH-YU CHANG; KAI-LUN YU; JEN-CHANG KO; Jann-Yuan Wang; Jann-Tay Wang; Li-Na Lee
臺大學術典藏	2021-03-11T08:34:20Z	Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan	Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Wang J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Chih-Hsin Lee; JEN-CHANG KO; LIH-YU CHANG; Ming-Chia Lee; Jann-Yuan Wang; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:20Z	Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan	Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Wang J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Chih-Hsin Lee; JEN-CHANG KO; LIH-YU CHANG; Ming-Chia Lee; Jann-Yuan Wang; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:20Z	Cementing an unwanted relationship	Chang C.-H.;Keng L.-T.;Jen-Chang Ko; CHIA-HAO CHANG; LI-TA KENG; JEN-CHANG KO
臺大學術典藏	2021-03-11T08:34:20Z	Cementing an unwanted relationship	Chang C.-H.;Keng L.-T.;Jen-Chang Ko; CHIA-HAO CHANG; LI-TA KENG; JEN-CHANG KO
臺大學術典藏	2021-03-11T08:34:19Z	Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study	Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T08:34:19Z	Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study	Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T08:34:19Z	Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study	Liao Y.-C.;Liao W.-Y.;Sun J.-L.;Jen-Chang Ko;Yu C.-J.; Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:19Z	Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study	Liao Y.-C.;Liao W.-Y.;Sun J.-L.;Jen-Chang Ko;Yu C.-J.; Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:19Z	Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study	Wei Y.-F.;Huang W.-T.;Liu T.-C.;Shieh J.-M.;Chian C.-F.;Wu M.-F.;Chang C.-C.;Lin C.-H.;Jen-Chang Ko;Lin C.-M.;Hsia T.-C.; Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏	2021-03-11T08:34:19Z	Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study	Wei Y.-F.;Huang W.-T.;Liu T.-C.;Shieh J.-M.;Chian C.-F.;Wu M.-F.;Chang C.-C.;Lin C.-H.;Jen-Chang Ko;Lin C.-M.;Hsia T.-C.; Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏	2021-03-11T08:34:18Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:18Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:18Z	Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells	Jen-Chang Ko;Chen J.-C.;Chen T.-Y.;Yen T.-C.;Ma P.-F.;Lin Y.-C.;Wu C.-H.;Peng Y.-S.;Zheng H.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:18Z	Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells	Jen-Chang Ko;Chen J.-C.;Chen T.-Y.;Yen T.-C.;Ma P.-F.;Lin Y.-C.;Wu C.-H.;Peng Y.-S.;Zheng H.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:18Z	Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells	Chen J.-C.;Jen-Chang Ko;Yen T.-C.;Chen T.-Y.;Lin Y.-C.;Ma P.-F.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:18Z	Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells	Chen J.-C.;Jen-Chang Ko;Yen T.-C.;Chen T.-Y.;Lin Y.-C.;Ma P.-F.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:17Z	Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study	Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Jen-Chang Ko;Lee L.-N.; Meng-Rui Lee; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N.
臺大學術典藏	2021-03-11T08:34:17Z	Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study	Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Jen-Chang Ko;Lee L.-N.; Meng-Rui Lee; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N.
臺大學術典藏	2021-03-11T08:34:17Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Jen-Chang Ko;Tsai J.-S.;Wang J.-Y.; MENG-RUI LEE; KAI-LUN YU; HUNG-YANG KUO; Tsung-Hao Liu; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏	2021-03-11T08:34:17Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Jen-Chang Ko;Tsai J.-S.;Wang J.-Y.; MENG-RUI LEE; KAI-LUN YU; HUNG-YANG KUO; Tsung-Hao Liu; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏	2021-03-11T08:34:17Z	Downregulation of xeroderma pigmentosum complementation group c expression by 17-allylamino-17-demethoxygeldanamycin enhances bevacizumab-induced cytotoxicity in human lung cancer cells	Chen J.-C.;Jen-Chang Ko;Taso Y.-C.;Cheng H.-H.;Chen T.-Y.;Yen T.-C.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Taso Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:17Z	Downregulation of xeroderma pigmentosum complementation group c expression by 17-allylamino-17-demethoxygeldanamycin enhances bevacizumab-induced cytotoxicity in human lung cancer cells	Chen J.-C.;Jen-Chang Ko;Taso Y.-C.;Cheng H.-H.;Chen T.-Y.;Yen T.-C.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Taso Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:16Z	Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study	Lee M.-R.;Huang H.-L.;Chen L.-C.;Yang H.-C.;Jen-Chang Ko;Cheng M.-H.;Chong I.-W.;Lee L.-N.;Wang J.-Y.;Dimopoulos G.; MENG-RUI LEE; Huang H.-L.; Lun-Che Chen; HAN-CHING YANG; JEN-CHANG KO; Cheng M.-H.; Chong I.-W.; Lee L.-N.; Wang J.-Y.; Dimopoulos G.
臺大學術典藏	2021-03-11T08:34:16Z	Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study	Lee M.-R.;Huang H.-L.;Chen L.-C.;Yang H.-C.;Jen-Chang Ko;Cheng M.-H.;Chong I.-W.;Lee L.-N.;Wang J.-Y.;Dimopoulos G.; MENG-RUI LEE; Huang H.-L.; Lun-Che Chen; HAN-CHING YANG; JEN-CHANG KO; Cheng M.-H.; Chong I.-W.; Lee L.-N.; Wang J.-Y.; Dimopoulos G.

Showing items 126-150 of 290 (12 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 0
	???header.visitor??? : 51925515 ???header.onlineuser??? : 891 ???header.sponsordeclaration???